Efficacy and safety of rufinamide in pediatric epilepsy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 189, doi. 10.1177/1756285613481083
- By:
- Publication type:
- Article
Works matching IS 17562856 AND DT 2013 AND VI 6 AND IP 3
Results: 6
1
2
Timing of cigarette smoking as a risk factor for multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 205, doi. 10.1177/1756285613479427
- By:
- Publication type:
- Article
3
Diagnosis and treatment of impulse control disorders in patients with movement disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 175, doi. 10.1177/1756285613476127
- By:
- Publication type:
- Article
4
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 199, doi. 10.1177/1756285613475835
- By:
- Publication type:
- Article
5
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 161, doi. 10.1177/1756285612474333
- By:
- Publication type:
- Article
6
Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 147, doi. 10.1177/1756285612472386
- By:
- Publication type:
- Article